DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received an average rating of “Buy” from the five analysts that are covering the company, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $6.10.
A number of research analysts have commented on the company. Cantor Fitzgerald restated an “overweight” rating and set a $5.00 price objective on shares of DocGo in a research note on Friday, September 20th. Needham & Company LLC reissued a “buy” rating and set a $7.00 price target on shares of DocGo in a research report on Thursday, August 8th.
Get Our Latest Stock Report on DCGO
Institutional Investors Weigh In On DocGo
DocGo Stock Performance
Shares of NASDAQ:DCGO opened at $3.61 on Tuesday. The stock has a 50-day simple moving average of $3.44 and a 200-day simple moving average of $3.32. The stock has a market capitalization of $369.38 million, a P/E ratio of 12.89, a PEG ratio of 2.88 and a beta of 0.89. DocGo has a 1 year low of $2.75 and a 1 year high of $6.36.
DocGo (NASDAQ:DCGO – Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $164.95 million for the quarter, compared to analysts’ expectations of $166.61 million. DocGo had a return on equity of 8.90% and a net margin of 3.97%. Analysts predict that DocGo will post 0.23 earnings per share for the current year.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
- Five stocks we like better than DocGo
- The Most Important Warren Buffett Stock for Investors: His Own
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.